Skip to main content
. Author manuscript; available in PMC: 2014 Sep 23.
Published in final edited form as: J Urol. 2009 Oct 17;182(6):2601–2606. doi: 10.1016/j.juro.2009.08.087

Figure 2.

Figure 2

Cancer-specific survival for 704 patients treated with radical and 239 patients treated with partial nephrectomy. Estimated cancer-specific survival rates (95% CI, number still at risk) at 1, 3, 5, 7, and 10 years following surgery were 98% (97 – 99, 640), 95% (93 – 96, 483), 91% (89 – 93, 354), 89% (86 – 91, 248), and 85% (81 – 89, 135), respectively, for patients treated with radical compared with 99.5% (99 – 100, 195), 98% (95 – 100, 140), 97% (93 – 99.7, 81), 93% (88 – 99, 33), and 90% (82 – 99, 15), respectively, for patients treated with partial nephrectomy.